Format

Send to

Choose Destination
J Cancer Educ. 2018 Mar 26. doi: 10.1007/s13187-018-1353-5. [Epub ahead of print]

Primary Care Providers' Intended Use of Decision Aids for Prostate-Specific Antigen Testing for Prostate Cancer Screening.

Author information

1
Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, MS F-76, Atlanta, GA, 30341, USA. srim@cdc.gov.
2
Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, MS F-76, Atlanta, GA, 30341, USA.

Abstract

Decision aids are tools intended to help people weigh the benefits and harms of a health decision. We examined primary care providers' perspective on use of decision aids and explored whether providers' beliefs and interest in use of a decision aid was associated with offering the prostate-specific antigen (PSA) test for early detection of prostate cancer. Data were obtained from 2016 DocStyles, an annual, web-based survey of U.S. healthcare professionals including primary care physicians (nā€‰=ā€‰1003) and nurse practitioners (nā€‰=ā€‰253). We found that the majority of primary care providers reported not using (patient) decision aids for prostate cancer screening, but were interested in learning about and incorporating these tools in their practice. Given the potential of decision aids to guide in informed decision-making, there is an opportunity for evaluating existing decision aids for prostate cancer screening for clinical use.

KEYWORDS:

Decision aids; Prostate cancer; Prostate cancer screening; Prostate specific antigen

PMID:
29582364
DOI:
10.1007/s13187-018-1353-5

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center